Benecyte, Inc.
Founded in 2023, Benecyte, Inc. is a US company based in Durham, North Carolina, developing allogeneic cytokine-induced killer (CIK) cells for cancer immunotherapies and extending our platform to solid tumors.
Founded in 2023, Benecyte, Inc. is a US company based in Durham, North Carolina, developing allogeneic cytokine-induced killer (CIK) cells for cancer immunotherapies and extending our platform to solid tumors.
Receive our latest blog posts directly in your inbox!